AGEN

Agenus Inc. - Common Stock (AGEN)

About Agenus Inc. - Common Stock (AGEN)

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Details

Daily high

$6.93

Daily low

$6.11

Price at open

$6.81

52 Week High

$10.31

52 Week Low

$2.71

Market cap

314.8M

Dividend yield

Volume

1.3M

Avg. volume

750,980

P/E ratio

2.63

Agenus Inc. - Common Stock News